These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 263545)

  • 1. Further studies on BL-3912A: effects on avoidance behavior of rats with low baselines and on reaction thresholds to electric footshock.
    Tilson HA; Chamberlain JH; Gylys JA
    Pharmacol Biochem Behav; 1977 Jun; 6(6):627-30. PubMed ID: 263545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral comparisons of R-2-amino-1-(2,5-dimethoxy-4-methylphenyl) butane (BL-3912A) with R-DOM and S-amphetamine.
    Tilson HA; Chamberlain JH; Gylys JA
    Psychopharmacology (Berl); 1977 Jan; 51(2):169-73. PubMed ID: 402669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular and gross behavioral effects of amphetamine, 2-amino-1-(2,5-dimethoxy-4-methylphenyl) propane (DOM) and 2-amino-1-(2,5-dimethoxy-4-methylphenyl) butane (BL-3912A) in the conscious dog.
    Buyniski JP; Smith ML; Bierwagen ME
    Res Commun Chem Pathol Pharmacol; 1974 Jun; 8(2):213-21. PubMed ID: 4859236
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of the effects of R-(-)-2-amino-1-(2,5-dimethoxy-4-methylphenyl) propane (DOM), r-(-)-2-amino-1-(2,5-dimethoxy-4-methylphenyl) butane (BL-3912A) and 5-hydroxytryptamine on non-innervated vascular smooth muscle.
    Dyer DC
    Res Commun Chem Pathol Pharmacol; 1976 Jul; 14(3):449-54. PubMed ID: 959651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral and neuropharmacological analysis of amphetamine and 2,5-dimethoxy-4-methylamphetamine in rats.
    Tilson HA; Baker TG; Chamberlain JH
    Psychopharmacologia; 1975 Nov; 44(3):229-39. PubMed ID: 1208759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioural effects of etiracetam in rats.
    Wolthuis OL
    Pharmacol Biochem Behav; 1981 Aug; 15(2):247-55. PubMed ID: 7312895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The behavioral effects of 2,5-dimethoxy-4-alkyl amphetamines.
    Morin RD; Benington F; Mitchell SR; Beaton JM; Bradley RJ; Smythies JR
    Experientia; 1975 Jan; 31(1):93-5. PubMed ID: 234850
    [No Abstract]   [Full Text] [Related]  

  • 8. Phenylakylamines with potential psychotherapeutic utility. 1. 2-Amino-1-(2,5-dimethoxy-4-methylphenyl)butane.
    Standridge RT; Howell HG; Gylys JA; Partyka RA; Shulgin AT
    J Med Chem; 1976 Dec; 19(12):1400-4. PubMed ID: 1003425
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthesis and evaluation of 2,3-dihydrobenzofuran analogues of the hallucinogen 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane: drug discrimination studies in rats.
    Nichols DE; Hoffman AJ; Oberlender RA; Riggs RM
    J Med Chem; 1986 Feb; 29(2):302-4. PubMed ID: 3950910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indolealkylamine and phenalkylamine hallucinogens. Effect of alpha-methyl and N-methyl substituents on behavioral activity.
    Glennon RA; Young R; Jacyno JM
    Biochem Pharmacol; 1983 Apr; 32(7):1267-73. PubMed ID: 6573879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [3H]DOB: a specific agonist radioligand for 5-HT2 serotonin receptors.
    Titeler M; Herrick K; Lyon RA; McKenney JD; Glennon RA
    Eur J Pharmacol; 1985 Oct; 117(1):145-6. PubMed ID: 4085543
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of dl-cathinone, d-amphetamine and cocaine on avoidance responding in rats and their interactions with haloperidol and methysergide.
    Huang D; Wilson MC
    Pharmacol Biochem Behav; 1984 May; 20(5):721-9. PubMed ID: 6739516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolongation of latencies for passive avoidance responses in rats treated with aniracetam or piracetam.
    Yamada K; Inoue T; Tanaka M; Furukawa T
    Pharmacol Biochem Behav; 1985 Apr; 22(4):645-8. PubMed ID: 3991773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amphetamine, conditioned stimulus, and nondebilitating preshock effects on activity and avoidance: further evidence for interactions between associative and nonassociative changes.
    Alleva E; de Acetis L; Amorico L; Bignami G
    Behav Neural Biol; 1983 Sep; 39(1):78-104. PubMed ID: 6661145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of lindane, DDT, and chlordecone on avoidance responding and seizure activity.
    Tilson HA; Shaw S; McLamb RL
    Toxicol Appl Pharmacol; 1987 Mar; 88(1):57-65. PubMed ID: 2436354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of 2,5-dimethoxy-4-methylamphetamine (DOM) on operant behavior: interactions with other neuroactive agents.
    Commissaris RL; Semeyn DR; Moore KE; Rech RH
    Commun Psychopharmacol; 1980; 4(5):393-404. PubMed ID: 6120791
    [No Abstract]   [Full Text] [Related]  

  • 17. Facilitation of shuttle-box avoidance behaviour in mice treated with nifedipine in combination with amphetamine.
    Vetulani J; Battaglia M; Castellano C; Sansone M
    Psychopharmacology (Berl); 1993; 113(2):217-21. PubMed ID: 7855184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facilitation of avoidance acquisition in rats produced by P-chlorophenylalanine or P-chloroamphetamine.
    Vorhees CV
    Pharmacol Biochem Behav; 1979 Apr; 10(4):569-76. PubMed ID: 156926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DOM-stimulus generalization to LSD and other hallucinogenic indolealkylamines.
    Glennon RA; Young R; Jacyno JM; Slusher M; Rosecrans JA
    Eur J Pharmacol; 1983 Jan; 86(3-4):453-9. PubMed ID: 6572591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further investigation of the discriminative stimulus properties of MDA.
    Glennon RA; Young R
    Pharmacol Biochem Behav; 1984 Apr; 20(4):501-5. PubMed ID: 6728867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.